134 related articles for article (PubMed ID: 5931205)
1. Non-resectable carcinoma of the prostate rendered resectable by endocrine therapy.
Chute R; Fox BM
J Urol; 1966 Apr; 95(4):577-9. PubMed ID: 5931205
[No Abstract] [Full Text] [Related]
2. [Hormone therapy in carcinoma of the prostate].
Marberger H
Wien Klin Wochenschr; 1966 Jul; 78(29):512-4 passim. PubMed ID: 5992834
[No Abstract] [Full Text] [Related]
3. Prostate cancer. Endocrine and cytotoxic therapy.
Smith PH
Recent Results Cancer Res; 1981; 78():154-72. PubMed ID: 7022593
[No Abstract] [Full Text] [Related]
4. Survival of patients with incidentally found microscopic cancer of the prostate: results of a clinical trial of conservative treatment.
Byar DP
J Urol; 1972 Dec; 108(6):908-13. PubMed ID: 5082745
[No Abstract] [Full Text] [Related]
5. [How should patients with prostate cancer be treated?].
Hvidt V
Ugeskr Laeger; 1977 Feb; 139(9):543-4. PubMed ID: 841747
[No Abstract] [Full Text] [Related]
6. [Modern therapy of prostate cancer].
Schneider HJ; Hienzsch E; Albert L
Z Alternsforsch; 1969; 22(2):149-54. PubMed ID: 5380261
[No Abstract] [Full Text] [Related]
7. [Resorption and effectiveness of implanted compressed hormones in carcinoma of the prostate].
Ziesche HW
Urol Int; 1965; 20(5):289-304. PubMed ID: 5863979
[No Abstract] [Full Text] [Related]
8. Current concepts concerning carcinoma of the prostate.
Skinner DG
Surg Annu; 1973; 5():393-406. PubMed ID: 4602222
[No Abstract] [Full Text] [Related]
9. [Hormonal therapy of prostatic carcinoma].
Martz G
Internist (Berl); 1968 Sep; 9(9):375-80. PubMed ID: 4918657
[No Abstract] [Full Text] [Related]
10. [Revaluation of estrogen therapy on prostate cancer].
Takezawa Y; Kobayashi M; Yamanaka H
Nihon Rinsho; 2000 Jul; 58 Suppl():223-7. PubMed ID: 11022718
[No Abstract] [Full Text] [Related]
11. [Hormonal treatments of prostate cancer].
Kuhn JM
Rev Prat; 1990 Nov; 40(25):2357-62. PubMed ID: 2124721
[No Abstract] [Full Text] [Related]
12. Estrogen therapy for prostate carcinoma.
Presti JC
JAMA; 1996 Apr; 275(15):1153. PubMed ID: 8609673
[No Abstract] [Full Text] [Related]
13. Cancer of the prostate.
N Engl J Med; 1968 Apr; 278(15):848-9. PubMed ID: 5642506
[No Abstract] [Full Text] [Related]
14. Paraplegia and paraparesis due to prostatic cancer. Use of intravenous diethylstilbestrol diphosphate.
Hawtrey CE; Welch MJ; Schmidt JD; Culp DA; Flocks RH
Urology; 1974 Oct; 4(4):431-4. PubMed ID: 4423432
[No Abstract] [Full Text] [Related]
15. Hormone therapy of prostatic bone metastases.
Huben RP
Adv Exp Med Biol; 1992; 324():305-16. PubMed ID: 1492625
[TBL] [Abstract][Full Text] [Related]
16. Cancer of the prostate.
Lancet; 1980 Nov; 2(8202):1009-10. PubMed ID: 6107632
[No Abstract] [Full Text] [Related]
17. [Hormonodependence and hormonotherapy in cancer of the prostate (author's transl)].
Juret P; Alperine G
J Radiol Electrol Med Nucl; 1974 Nov; 55(11):802-4. PubMed ID: 4452960
[No Abstract] [Full Text] [Related]
18. [Orchidectomy and oestrogen therapy of carcinoma of the prostate (author's transl)].
Straube W; Braun JS
Urologe A; 1974 Jul; 13(4 Pt A):198-201. PubMed ID: 4137442
[No Abstract] [Full Text] [Related]
19. Hormone therapy in prostatic cancer.
Smith PH; Akdas A; Mason MK; Richards B; Robinson MR; de Pauw M; Sylvester R
Acta Urol Belg; 1980 Jan; 48(1):98-105. PubMed ID: 7001876
[No Abstract] [Full Text] [Related]
20. [Hormone therapy for prostatic carcinoma and hypertrophy].
Hanschke HJ
Dtsch Med Wochenschr; 1969 Mar; 94(13):677-8. PubMed ID: 4180637
[No Abstract] [Full Text] [Related]
[Next] [New Search]
